Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma

Journal of Glaucoma

Volumn 14, Issue 1, 2005, Pages 64-69

  Määttä, Marko ^a   Tervahartiala, Taina ^a   Harju, Mika ^a   Airaksinen, Juhani ^b   Autio Harmainen, Helena ^c   Sorsa, Timo ^a,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d ORTON Invalid Foundation   (Finland)

Author keywords

ELISA; MMP; Proteolysis; TIMP; Western blotting; Zymography

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 12844269167     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000145812.39224.0a     Document Type: Article

References (40)

1. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that become a prince. Nat Rev Mol Cell Biol. 2002;3:207-214.
2. Fassina G, Ferrari N, Brigati C, et al. Tissue inhibitors of metalloproteinases: regulation and biological activities. Clin Exp Metastasis. 2000;18:111-120.
3. Bill A, Maepea O. Mechanisms and routes of aqueous humor drainage. In: Albert DM, Jakotiec FA, eds. Principles and Practices of Ophthalmology. Philadelphia: WB Saunders; 1994:206-226.
4. Alexander JP, Samples JP, Van Buskirk EM, et al. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
5. Huang SH, Adamis AP, Wiederschain DG, et al. Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Eye Res. 1996;62:481-490.
6. Kee C, Son S, Ahn BH. The relationship between gelatinase A activity in aqueous humor and glaucoma. J Glaucoma. 1999;8:51-55.
7. Knepper PA, Goossens W, Palmberg PF. Glycosaminoglycan stratification of the juxtacanalicular tissue in normal and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:2414-2425.
8. Ueda J, Wentz-Hunter K, Yue BYJT. Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest Ophthalmol Vis Sci. 2002;43:1068-1076.
9. Tripathi RC, Li J, Chan WFA, et al. Aqueous humor in glaucomatous eyes contains an increased level of TGF-β2. Exp Eye Res. 1994;59:723-728.
10. González-Avila G, Ginebra M, Hayakawa T, et al. Collagen metabolism in human aqueous humor from primary open-angle glaucoma. Arch Ophthalmol. 1995;113:1319-1323.
11. Strongin AY, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem. 1995;270:5331-5338.
12. Bradley JMB, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
13. Bradley JMB, Kelley MJ, Zhu XH, et al. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2001;42:1505-1513.
14. Kim CY, Kim SS, Koh HJ, et al. Effect of IOP elevation on matrix metalloproteinase-2 in rabbit anterior chamber. Korean J Ophthalmol. 2000;14:27-31.
15. Schlötzer-Schrehardt U, Lommatzsch J, Kuchle M, et al. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndorome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44:1117-1125.
16. Sorsa T, Ding Y, Salo T, et al. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and Western blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci. 1994;732:112-131.
17. Paju A, Sorsa T, Tervahartiala T, et al. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation. Br J Cancer. 2001;84:1363-1371.
18. Lauhio A, Salo T, Ding Y, et al. in vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol. 1994;98:21-28.
19. Sorsa T, Salo T, Koivunen E, et al. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem. 1997;272:21067-21074.
20. Prikk K, Maisi P, Pirilä E, et al. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab Invest. 2002;82:1535-1545.
21. Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
22. Tervahartiala T, Ingman T, Sorsa T, et al. Proteolytic enzymes as indicators of periodontal health in gingival crevicular fluid of patients with Sjögren's syndrome. Eur J Oral Sci. 1995;103:11-16.
23. Lehti K, Valtanen H, Lohi J, et al. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem. 2000;275:15006-15013.
24. Hanemaaijer R, Sorsa T, Konttinen Y, et al. Matrix metalloproteinase-8 is expressed by rheumatoid synovial fibroblasts and endothelial cells. Regulation of tumor necrosis factor-α and doxycycline. J Biol Chem. 1997;272:31504-31509.
25. Küchle M, Ho TS, Nguyen NX, et al. Protein quantification and electrophoresis in aqueous humor of pseudoexfoliation eyes. Invest Ophthalmol Vis Sci. 1994;35:748-752.
26. Murphy G, Crabbe T. Gelatinases A and B. Methods Enzymol. 1995;248:470-484.
27. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987;6:1899-1904.
28. Welge-Lüzen U, May CA, Lütjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-β1 and TGF-β2. Invest Ophthalmol Vis Sci. 2000;41:2229-2238.
29. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.
30. Koliakos GG, Schlötzer-Schrehardt U, Konstas AGP, et al. Transforming and insulin-like growth factors in the aqueous humor of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2001;239:482-487.
31. El-Shabrawi YG, Christen WG, Foster SC. Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis. Curr Eye Res. 2000;20:211-214.
32. Knepper PA, Goossens W, Mayanil CS. CD44H localization in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1998;39:673-680.
33. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999;13:35-48.
34. Holopainen JM, Moilanen JA, Sorsa T, et al. Activation of matrix metalloproteinase-8 by membrane type 1-MMP and their expression in human tears after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2003;44:2550-2556.
35. Maisi P, Prikk K, Sepper R, et al. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS. 2002;110:771-782.
36. Tervahartiala T, Pirila E, Ceponis A, et al. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res. 2000;79:1969-1977.
37. Li H, Bauzon DE, Xu X, et al. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Mol Carcinog. 1998;22:84-94.
38. Wahlgren J, Maisi P, Sorsa T, et al. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J Pathol. 2001;194:217-224.
39. Hasty KA, Hibbs MS, Kang AH, et al. Secreted forms of human neutrophil collagenase. J Biol Chem. 1986;261:5645-5650.
40. Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999;31:34-45.